Ondřej Havránek

1.1k total citations
45 papers, 538 citations indexed

About

Ondřej Havránek is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ondřej Havránek has authored 45 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Pathology and Forensic Medicine and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ondřej Havránek's work include Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (10 papers) and BRCA gene mutations in cancer (6 papers). Ondřej Havránek is often cited by papers focused on Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (10 papers) and BRCA gene mutations in cancer (6 papers). Ondřej Havránek collaborates with scholars based in Czechia, United States and Ukraine. Ondřej Havránek's co-authors include Anton Tkachenko, Zdeněk Kleibl, Pavel Souček, R. Eric Davis, Marek Trněný, Petr Pohlreich, Jan Novotný, Stefan Köhrer, Petra Kleiblová and Jan A. Burger and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and PLoS ONE.

In The Last Decade

Ondřej Havránek

39 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ondřej Havránek Czechia 13 240 191 154 122 91 45 538
Stéphanie Struski France 16 264 1.1× 94 0.5× 112 0.7× 134 1.1× 106 1.2× 30 596
Alona Merkulova United States 11 180 0.8× 117 0.6× 123 0.8× 120 1.0× 58 0.6× 16 516
Susanna Mannisto Finland 13 299 1.2× 126 0.7× 128 0.8× 50 0.4× 87 1.0× 26 661
Takashi Akasaka Japan 15 222 0.9× 323 1.7× 194 1.3× 229 1.9× 25 0.3× 45 660
Quangeng Zhang China 9 352 1.5× 163 0.9× 134 0.9× 99 0.8× 33 0.4× 12 747
Mattias Jansson Sweden 12 166 0.7× 86 0.5× 64 0.4× 159 1.3× 75 0.8× 22 401
Michelle K. Manske United States 11 110 0.5× 242 1.3× 149 1.0× 178 1.5× 27 0.3× 19 568
Carlos A Tirado United States 14 336 1.4× 77 0.4× 112 0.7× 137 1.1× 58 0.6× 80 660
Adéla Berková Czechia 11 172 0.7× 127 0.7× 76 0.5× 140 1.1× 17 0.2× 26 391
Hisao Nagoshi Japan 12 299 1.2× 118 0.6× 136 0.9× 54 0.4× 23 0.3× 38 520

Countries citing papers authored by Ondřej Havránek

Since Specialization
Citations

This map shows the geographic impact of Ondřej Havránek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ondřej Havránek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ondřej Havránek more than expected).

Fields of papers citing papers by Ondřej Havránek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ondřej Havránek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ondřej Havránek. The network helps show where Ondřej Havránek may publish in the future.

Co-authorship network of co-authors of Ondřej Havránek

This figure shows the co-authorship network connecting the top 25 collaborators of Ondřej Havránek. A scholar is included among the top collaborators of Ondřej Havránek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ondřej Havránek. Ondřej Havránek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tkachenko, Anton, Mohammad A. Alfhili, Jawaher Alsughayyir, et al.. (2025). Current understanding of eryptosis: mechanisms, physiological functions, role in disease, pharmacological applications, and nomenclature recommendations. Cell Death and Disease. 16(1). 467–467. 5 indexed citations
2.
Petrák, Jir̆ı́, Ladislav Anděra, Ondřej Havránek, et al.. (2025). Long-term adaptation of lymphoma cell lines to hypoxia is mediated by diverse molecular mechanisms that are targetable with specific inhibitors. Cell Death Discovery. 11(1). 65–65. 2 indexed citations
3.
Tkachenko, Anton & Ondřej Havránek. (2025). Cell death signaling in human erythron: erythrocytes lose the complexity of cell death machinery upon maturation. APOPTOSIS. 30(3-4). 652–673. 3 indexed citations
4.
Koning, Marvyn T., Ruben A. L. de Groen, Edwin Quinten, et al.. (2024). Antigen-independent, autonomous B cell receptor signaling drives activated B cell DLBCL. The Journal of Experimental Medicine. 221(5). 5 indexed citations
5.
Anděra, Ladislav, Adéla Berková, Zuzana Zemanová, et al.. (2024). Impact of PIK3CA gain and PTEN loss on mantle cell lymphoma biology and sensitivity to targeted therapies. Blood Advances. 8(20). 5279–5289. 2 indexed citations
6.
Tkachenko, Anton & Ondřej Havránek. (2024). Erythronecroptosis: an overview of necroptosis or programmed necrosis in red blood cells. Molecular and Cellular Biochemistry. 479(12). 3273–3291. 12 indexed citations
7.
Tkachenko, Anton & Ondřej Havránek. (2023). Redox Status of Erythrocytes as an Important Factor in Eryptosis and Erythronecroptosis. Folia Biologica. 69(4). 116–126. 7 indexed citations
8.
Tkachenko, Anton, et al.. (2023). B-Cell Receptor Signaling and Beyond: The Role of Igα (CD79a)/Igβ (CD79b) in Normal and Malignant B Cells. International Journal of Molecular Sciences. 25(1). 10–10. 34 indexed citations
9.
Górniak, Patryk, Ondřej Havránek, Anna Polak, & Przemysław Juszczyński. (2023). Role of Autoantigen Induced-B-Cell Receptor Internalization and Its Inhibition for the Biology and Survival of Diffuse Large B-Cell Lymphoma (DLBCL) Cells. Blood. 142(Supplement 1). 4141–4141. 1 indexed citations
10.
Průková, Dana, Ladislav Anděra, Zuzana Nahácka, et al.. (2019). Cotargeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal In Vivo in Relapsed Mantle Cell Lymphoma. Clinical Cancer Research. 25(14). 4455–4465. 63 indexed citations
11.
Krhút, Jan, et al.. (2018). 2)proPSA a Index zdravé prostaty (PHI) v predikci výskytu karcinomu prostaty v transrektálních biopsiích. 22(1). 40–47. 1 indexed citations
12.
Vangapandu, Hima V., Ondřej Havránek, Mary Ayres, et al.. (2017). B-cell Receptor Signaling Regulates Metabolism in Chronic Lymphocytic Leukemia. Molecular Cancer Research. 15(12). 1692–1703. 40 indexed citations
13.
Havránek, Ondřej, Petra Kleiblová, J. Hojný, et al.. (2015). Association of Germline CHEK2 Gene Variants with Risk and Prognosis of Non-Hodgkin Lymphoma. PLoS ONE. 10(10). e0140819–e0140819. 36 indexed citations
14.
Havránek, Ondřej, Stefan Koehrer, Zhiqiang Wang, et al.. (2014). The B-Cell Receptor Is Required for Optimal Viability, Growth, and Chemotherapy Resistance of Diffuse Large B-Cell Lymphoma Cell Lines of the Germinal Center B-Cell Subtype. Blood. 124(21). 493–493. 3 indexed citations
15.
Havránek, Ondřej, et al.. (2013). Metoda akcelerované rehabilitace v perioperační péči u urologických výkonů. 17(4). 221–226. 1 indexed citations
16.
Krhút, Jan, et al.. (2012). Využití extraanatomického stentu (EAS) u pacientů s pokročilým maligním onemocněním. 16(4). 241–246. 1 indexed citations
17.
Havránek, Ondřej, et al.. (2011). Úloha laparoskopie v diagnostice a léčbě nehmatných varlat. 15(3). 167–171.
18.
Havránek, Ondřej, Martin Špaček, Petr Hubáček, et al.. (2011). Alterations of CHEK2 forkhead-associated domain increase the risk of Hodgkin lymphoma. Neoplasma. 58(5). 392–395. 13 indexed citations
19.
Krhút, Jan, et al.. (2009). [Combination therapy with anticholinergics and alpha-blockers for the treatment of overactive bladder in female patients--pilot study].. PubMed. 74(6). 416–20. 2 indexed citations
20.
Havránek, Ondřej, et al.. (2008). Využití laparoskopie v diagnosticko-terapeutickém algoritmu u pacientů se spontánní rupturou močového měchýře: tři případy z našeho pracoviště. 12(1). 49–54. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stéphanie Struski Breakdown of academic impact, for papers by Alona Merkulova Breakdown of academic impact, for papers by Susanna Mannisto Breakdown of academic impact, for papers by Takashi Akasaka Breakdown of academic impact, for papers by Quangeng Zhang Breakdown of academic impact, for papers by Mattias Jansson Breakdown of academic impact, for papers by Michelle K. Manske Breakdown of academic impact, for papers by Carlos A Tirado Breakdown of academic impact, for papers by Adéla Berková Breakdown of academic impact, for papers by Hisao Nagoshi
Rankless by CCL
2026